X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (451) 451
Publication (96) 96
Newspaper Article (41) 41
Book Review (29) 29
Conference Proceeding (26) 26
Book Chapter (8) 8
Book / eBook (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (237) 237
humans (229) 229
oncology (212) 212
female (140) 140
pediatrics (110) 110
osteosarcoma (107) 107
child (105) 105
hematology (97) 97
animals (91) 91
article (89) 89
male (89) 89
adolescent (78) 78
mice (77) 77
cancer (76) 76
cell line, tumor (72) 72
xenograft model antitumor assays (67) 67
adult (66) 66
chemotherapy (66) 66
developmental therapeutics (66) 66
preclinical testing (65) 65
osteosarcoma - pathology (53) 53
bone neoplasms - pathology (51) 51
osteosarcoma - drug therapy (51) 51
mice, scid (46) 46
bone neoplasms - drug therapy (43) 43
tumors (39) 39
child, preschool (38) 38
osteosarcoma - genetics (36) 36
antineoplastic agents - pharmacology (35) 35
osteosarcoma - metabolism (35) 35
research (35) 35
expression (34) 34
sarcoma (34) 34
prognosis (32) 32
bone neoplasms - genetics (31) 31
metastasis (31) 31
acute lymphoblastic-leukemia (30) 30
mice, inbred balb c (30) 30
survival (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
middle aged (29) 29
children (28) 28
osteogenic-sarcoma (28) 28
abridged index medicus (26) 26
surgery (25) 25
neoplasms - drug therapy (24) 24
treatment outcome (24) 24
bone neoplasms - metabolism (23) 23
in-vivo (23) 23
bone cancer (22) 22
care and treatment (22) 22
cells (22) 22
neoplasms, experimental - drug therapy (22) 22
aged (21) 21
antineoplastic agents - therapeutic use (21) 21
cell proliferation - drug effects (21) 21
tumor cells, cultured (21) 21
cancer models (20) 20
high-dose methotrexate (20) 20
methotrexate (20) 20
preoperative chemotherapy (20) 20
young adult (20) 20
drug evaluation, preclinical (19) 19
drug resistance, neoplasm (19) 19
infant (19) 19
prognostic-factors (19) 19
survival rate (19) 19
bone neoplasms - mortality (18) 18
ewing sarcoma (18) 18
phase-ii (18) 18
analysis (17) 17
disease-free survival (17) 17
leukemia (17) 17
bone neoplasms - therapy (16) 16
immunohistochemistry (16) 16
mice, nude (16) 16
osteosarcoma - mortality (16) 16
solid tumors (16) 16
apoptosis (15) 15
gene expression (15) 15
gene expression regulation, neoplastic (15) 15
genetic aspects (15) 15
adjuvant chemotherapy (14) 14
bone (14) 14
cell proliferation (14) 14
neoadjuvant chemotherapy (14) 14
osteosarcoma - therapy (14) 14
retrospective studies (14) 14
therapy (14) 14
drug screening assays, antitumor (13) 13
gene (13) 13
high-grade osteosarcoma (13) 13
in-vitro (13) 13
lung neoplasms - secondary (13) 13
mice, inbred nod (13) 13
models (13) 13
mutation (13) 13
resistance (13) 13
reverse transcriptase polymerase chain reaction (13) 13
tumor (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1022 - 1023
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 04/2019, Volume 9, Issue 1, pp. 6161 - 13
Journal Article
by Sampson, JN and Wheeler, WA and Yeager, M and Panagiotou, O and Wang, Z and Berndt, SI and Lan, Q and Abnet, CC and Amundadottir, LT and Figueroa, JD and Landi, MT and Mirabello, L and Savage, SA and Taylor, PR and De Vivo, I and McGlynn, KA and Purdue, MP and Rajaraman, P and Adami, HO and Ahlbom, A and Albanes, D and Amary, MF and An, SJ and Andersson, U and Andriole, G and Andrulis, IL and Angelucci, E and Ansell, SM and Arici, C and Armstrong, BK and Arslan, AA and Austin, MA and Baris, D and Barkauskas, DA and Bassig, BA and Becker, N and Benavente, Y and Benhamou, S and Berg, C and Van Den Berg, D and Bernstein, L and Bertrand, KA and Birmann, BM and Black, A and Boeing, H and Boffetta, P and Boutron-Ruault, MC and Bracci, PM and Brinton, L and Brooks-Wilson, AR and Bueno-De-Mesquita, HB and Burdett, L and Buring, J and Butler, MA and Cai, QY and Cancel-Tassin, G and Canzian, F and Carrato, A and Carreon, T and Carta, A and Chan, JKC and Chang, ET and Chang, GC and Chang, IS and Chang, J and Chang-Claude, J and Chen, CJ and Chen, CY and Chen, C and Chen, CH and Chen, HY and Chen, KX and Chen, KY and Chen, KC and Chen, Y and Chen, YH and Chen, YS and Chen, YM and Chien, LH and Chirlaque, MD and Choi, JE and Choi, YY and Chow, WH and Chung, CC and Clavel, J and Clavel-Chapelon, F and Cocco, P and Colt, JS and Comperat, E and Conde, L and Connors, JM and Conti, D and Cortessis, VK and Cotterchio, M and Cozen, W and Crouch, S and Crous-Bou, M and Cussenot, O and Davis, FG and Ding, T and ... and Medicinska fakulteten and Institutionen för strålningsvetenskaper and Umeå universitet and Institutionen för folkhälsa och klinisk medicin and Urologi och andrologi and Kirurgi and Näringsforskning and Institutionen för kirurgisk och perioperativ vetenskap and Onkologi
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 12/2015, Volume 107, Issue 12, p. 1
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2015, Volume 62, Issue 1, pp. 91 - 98
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 02/2019, Volume 66, Issue 2, pp. e27524 - n/a
Background Patients with recurrent or refractory osteosarcoma have a poor prognosis with less than 30% surviving two years. Eribulin is a synthetic analog of... 
osteosarcoma | eribulin | TRIAL | SOLID TUMORS | ONCOLOGY | SARCOMA | METHOTREXATE | PEDIATRICS | TESTING STAGE 1 | HEMATOLOGY | CHEMOTHERAPY | Biomedical materials | Bone cancer | Toxicity | Osteosarcoma | Medical prognosis | Antitumor activity | Biocompatibility | Children | Patients | Disease control | Neutropenia | Anticancer properties
Journal Article
Oncology Times, ISSN 0276-2234, 06/2015, Volume 37, Issue 12, pp. 1 - 15
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, pp. e106249 - e106249
Background: Survival outcomes for patients with osteosarcoma (OS) have remained stagnant over the past three decades. Insulin-like growth factor 1 receptor... 
BREAST-CANCER | FIGITUMUMAB | PREDICTORS | MULTIDISCIPLINARY SCIENCES | IMATINIB | IGF-BINDING PROTEIN-3 | PHASE-II | RISK | MONOCLONAL-ANTIBODY | FACTOR-I RECEPTOR | CHEMOTHERAPY | Osteosarcoma - drug therapy | Receptor, IGF Type 1 - antagonists & inhibitors | Neoplasm Proteins - biosynthesis | Humans | Male | Neoplasm Proteins - antagonists & inhibitors | Receptor, IGF Type 1 - biosynthesis | Mice, SCID | Xenograft Model Antitumor Assays | RNA, Messenger - biosynthesis | Animals | Antibodies, Neoplasm - pharmacology | RNA, Neoplasm - biosynthesis | Cell Line, Tumor | Female | Antineoplastic Agents - pharmacology | Mice | Gene Expression Regulation, Neoplastic - drug effects | Osteosarcoma - metabolism | Osteosarcoma - pathology | Cell proliferation | Therapy | Pediatrics | Biotechnology | Flow cytometry | Copy number | Exons | Leukemia | Xenotransplantation | Colorectal cancer | Antibodies | Clinical trials | Oncology | Insulin-like growth factors | Metastasis | Kinases | Bone surgery | Cancer therapies | Cell surface | Osteosarcoma | Immunotherapy | Xenografts | Biocompatibility | Bioindicators | Medical research | Hematology | Breast cancer | Gene expression | Insulin | Patients | Medicine | Cytometry | Bone cancer | Hospitals | Medical prognosis | Cell lines | Biomarkers | Mutation | Tumors | Apoptosis | Index Medicus | Biomedical materials
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 11/2011, Volume 68, Issue 5, pp. 1291 - 1304
Journal Article